Free Trial

ZIVO Bioscience (ZIVO) Competitors

ZIVO Bioscience logo
$15.57 -0.14 (-0.88%)
As of 10:53 AM Eastern

ZIVO vs. GOSS, CADL, OCGN, TSVT, TERN, PVLA, INZY, LFCR, AVIR, and NGNE

Should you be buying ZIVO Bioscience stock or one of its competitors? The main competitors of ZIVO Bioscience include Gossamer Bio (GOSS), Candel Therapeutics (CADL), Ocugen (OCGN), 2seventy bio (TSVT), Terns Pharmaceuticals (TERN), Palvella Therapeutics (PVLA), Inozyme Pharma (INZY), Lifecore Biomedical (LFCR), Atea Pharmaceuticals (AVIR), and Neurogene (NGNE). These companies are all part of the "pharmaceutical products" industry.

ZIVO Bioscience vs.

ZIVO Bioscience (NASDAQ:ZIVO) and Gossamer Bio (NASDAQ:GOSS) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, community ranking, analyst recommendations, earnings, risk, profitability and media sentiment.

In the previous week, Gossamer Bio had 7 more articles in the media than ZIVO Bioscience. MarketBeat recorded 7 mentions for Gossamer Bio and 0 mentions for ZIVO Bioscience. Gossamer Bio's average media sentiment score of 0.61 beat ZIVO Bioscience's score of 0.00 indicating that Gossamer Bio is being referred to more favorably in the news media.

Company Overall Sentiment
ZIVO Bioscience Neutral
Gossamer Bio Positive

ZIVO Bioscience has higher earnings, but lower revenue than Gossamer Bio. Gossamer Bio is trading at a lower price-to-earnings ratio than ZIVO Bioscience, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ZIVO Bioscience$15.85K3,746.12-$7.78M-$4.93-3.16
Gossamer Bio$124.59M2.14-$179.82M-$0.23-5.11

Gossamer Bio has a consensus price target of $7.75, indicating a potential upside of 559.57%. Given Gossamer Bio's stronger consensus rating and higher probable upside, analysts clearly believe Gossamer Bio is more favorable than ZIVO Bioscience.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ZIVO Bioscience
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Gossamer Bio
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00

ZIVO Bioscience has a beta of 0.03, meaning that its stock price is 97% less volatile than the S&P 500. Comparatively, Gossamer Bio has a beta of 1.82, meaning that its stock price is 82% more volatile than the S&P 500.

Gossamer Bio received 58 more outperform votes than ZIVO Bioscience when rated by MarketBeat users. Likewise, 67.09% of users gave Gossamer Bio an outperform vote while only 60.74% of users gave ZIVO Bioscience an outperform vote.

CompanyUnderperformOutperform
ZIVO BioscienceOutperform Votes
99
60.74%
Underperform Votes
64
39.26%
Gossamer BioOutperform Votes
157
67.09%
Underperform Votes
77
32.91%

ZIVO Bioscience's return on equity of 0.00% beat Gossamer Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
ZIVO BioscienceN/A N/A -2,240.92%
Gossamer Bio N/A -127.28%-22.12%

12.8% of ZIVO Bioscience shares are owned by institutional investors. Comparatively, 81.2% of Gossamer Bio shares are owned by institutional investors. 21.5% of ZIVO Bioscience shares are owned by company insiders. Comparatively, 6.7% of Gossamer Bio shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Gossamer Bio beats ZIVO Bioscience on 12 of the 17 factors compared between the two stocks.

Get ZIVO Bioscience News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZIVO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ZIVO vs. The Competition

MetricZIVO BioscienceBiological Products IndustryMedical SectorNASDAQ Exchange
Market Cap$59.90M$2.95B$5.34B$8.46B
Dividend YieldN/A1.65%5.29%4.18%
P/E Ratio-3.2231.6726.8719.78
Price / Sales3,779.32420.24404.10138.41
Price / CashN/A168.6838.2534.64
Price / Book-19.403.216.774.54
Net Income-$7.78M-$72.35M$3.22B$247.85M
7 Day Performance-12.72%0.21%1.43%1.31%
1 Month Performance-16.45%1.82%9.45%9.43%
1 Year Performance96.87%-18.84%20.32%10.33%

ZIVO Bioscience Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ZIVO
ZIVO Bioscience
N/A$15.57
-0.9%
N/A+96.9%$59.38M$15,850.00-3.1910News Coverage
GOSS
Gossamer Bio
3.933 of 5 stars
$1.20
+3.4%
$7.75
+545.8%
+95.1%$272.76M$124.59M-3.75180Analyst Revision
CADL
Candel Therapeutics
1.9321 of 5 stars
$5.43
+0.2%
$21.00
+286.7%
-30.5%$272.06M$120,000.00-3.1460News Coverage
OCGN
Ocugen
1.0095 of 5 stars
$0.93
+1.8%
$6.00
+544.6%
-48.3%$271.82M$4.52M-5.1780High Trading Volume
TSVT
2seventy bio
1.2586 of 5 stars
$5.00
flat
$4.25
-15.0%
N/A$266.15M$48.37M-2.69440
TERN
Terns Pharmaceuticals
4.101 of 5 stars
$3.02
+2.7%
$15.63
+417.4%
-51.6%$263.76MN/A-2.5640Positive News
PVLA
Palvella Therapeutics
3.917 of 5 stars
$23.72
+7.3%
$46.29
+95.1%
N/A$262.25M$42.81M-1.96N/APositive News
Gap Up
High Trading Volume
INZY
Inozyme Pharma
3.0604 of 5 stars
$3.96
flat
$11.75
+196.7%
-10.2%$255.67MN/A-2.5450
LFCR
Lifecore Biomedical
1.7977 of 5 stars
$6.72
+0.7%
$8.00
+19.0%
+23.7%$248.81M$130.31M-12.00690News Coverage
Insider Trade
AVIR
Atea Pharmaceuticals
2.7395 of 5 stars
$2.90
+1.8%
$6.00
+106.9%
-18.8%$248.18MN/A-1.4070Positive News
NGNE
Neurogene
3.3236 of 5 stars
$17.28
-4.2%
$44.60
+158.1%
-44.3%$246.45M$925,000.00-3.9790Gap Down

Related Companies and Tools


This page (NASDAQ:ZIVO) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners